Yohimbine is a potent, unpredictable alkaloid often mislabeled in common dietary supplements.
In short: Marketed for weight loss and sexual performance, yohimbine is a complex chemical that lacks clinical evidence for these uses. Often derived from endangered African trees, the substance is notoriously difficult to dose, with supplements frequently containing either no active ingredient or dangerously high, potentially fatal, levels of the drug.
Yohimbine is an indole alkaloid found in the bark of the African Pausinystalia johimbe tree and the South American Aspidosperma quebracho-blanco. Although it was once thought these plants produced different compounds, 1972 research confirmed that quebrachine, isolated from the latter, is chemically identical to yohimbine. The compound acts as a selective antagonist at pre-synaptic alpha-2 adrenergic receptors, facilitating the release of neurotransmitters like norepinephrine and nitric oxide. While this mechanism has led to its use in veterinary medicine to reverse xylazine effects, its application in humans is fraught with risk.
The supplement industry frequently markets yohimbe preparations for libido, bodybuilding, and weight loss, yet these products are largely unregulated. Studies reveal that labeling is often misleading, with content levels varying wildly between brands. In 2022, the Tennessee Poison Center warned that these products could cause fatal cardiovascular events or seizures. Because the P. johimbe tree is endangered and scarce, harvesters often adulterate bark with other species, further complicating the chemical profile of any resulting extract. Consequently, many countries have banned yohimbine supplements entirely.
Beyond the danger of variable dosing, yohimbine is known to induce significant anxiety, irritability, and restlessness. In clinical settings, it has been studied for potential roles in treating erectile dysfunction or enhancing exposure therapy for PTSD, but evidence remains insufficient to support its efficacy. Furthermore, yohimbine interacts dangerously with various prescription medications, potentially leading to heart failure or death. While pharmaceutical-grade yohimbine hydrochloride exists, it is rarely prescribed and is not licensed for most conditions, underscoring the gap between its scientific study and its common, often hazardous, over-the-counter use.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Yohimbine
To cite this card, link to https://intellectplus.co.uk/app/technology-yohimbine.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Inventions · More in Technology · Latest · A–Z · All topics